Aviva’s Bruker BRKR Stock Holding History

Aviva’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-35,483	Closed	-$2.45M	–	860
2024 Q3	$2.45M	Buy	+35,483	New	+$2.29M	0.01%	527

Other funds holding BRKR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Aviva's BRKR Position: Q4 2024 in Review

Aviva sold out of Bruker (BRKR) in Q4 2024, closing a stake of 35,483 shares — an estimated $2.45M sold.

Aviva first reported a position in BRKR in Q3 2024 and held it in 1 quarter. The position peaked at $2.45M in Q3 2024. 367 funds tracked by Wall St. Rank hold BRKR as of Q4 2024.

Aviva reported no remaining Bruker position as of Q4 2024 after selling out during the quarter.
Aviva sold 35,483 Bruker shares in Q4 2024, an estimated $2.45M.
Aviva first reported a position in Bruker in Q3 2024 and held it in 1 quarter.
Aviva's Bruker position peaked at $2.45M in Q3 2024.
367 funds tracked by Wall St. Rank held Bruker as of Q4 2024.

Based on Aviva's 13F filing for Q4 2024, filed 13 Feb 2025.